The Appendix 4E released today has a lot of info. One piece that sticks out (especially after the 4C reported no revenue for the last quarter):
"In the weeks following 30 June 2012, orders were received for additional implants totalling EU 0.446 (approximately $0.550 million) that will be reported in the 2012/13 financial year."
So sales for FY10/11 were $1.041 million.
Sales for FY11/12 were $0.722 million.
Sales in first weeks of FY12/13 were $0.550 million.
After a slight dip, we're now moving toward solid growth.
revenue update
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.11 |
Change
-0.390(2.69%) |
Mkt cap ! $706.3M | |||
| Open | High | Low | Value | Volume |
| $14.48 | $14.70 | $14.11 | $1.013M | 70.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 242 | $14.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.16 | 645 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |